Aytu BioScience to Report Second Fiscal 2021 Results and Provide Business Update on Thursday, February 11, 2021
Live Conference Call and Webcast at 4:30 PM ET ENGLEWOOD, CO / ACCESSWIRE / February 4, 2021 / Aytu BioScience,...
News
Secarna Pharmaceuticals Appoints Alexander Gebauer, MD, PhD as CEO and Managing Director
MUNICH/MARTINSRIED, GERMANY / ACCESSWIRE / February 4, 2021 / Secarna Pharmaceuticals GmbH & Co. KG ("Secarna"), a biopharmaceutical company focusing...
Neutra Focused on Growth
KATY, TX / ACCESSWIRE / February 4, 2021 / Neutra Corp. (OTC PINK:NTRR) ("Neutra" or "the Company") has decided to...
CureVac Announces Full Exercise of Underwriters’ Option to Purchase Additional Common Shares
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / February 4, 2021 / CureVac N.V. (NASDAQ:CVAC) ("CureVac" or the "Company"), a...
Parexel and NeoGenomics Announce Strategic Collaboration in Precision Medicine to Improve Study Designs and Accelerate Patient Matching in Oncology Clinical Trials
Access to industry-leading genomic database and real-world evidence designed to optimize trial design, site selection, clinical trial matching and translational...
Biogen Announces Cash Tender Offer for 5.200% Senior Notes Due 2045 Open to Certain Holders Only
CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (“Biogen”) (Nasdaq: BIIB) today announced the commencement of an offer...
Indegene Releases The Healthcare Customer Experience Playbook – A Prescriptive Guide to Orchestrating Outstanding HCP Experiences
At least 1 in 3 Health Care Professionals (HCPs) are not satisfied with their channel experience Source: The Healthcare CX...
Stereotaxis to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
ST. LOUIS, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the...
GCAC Announces Health Canada Medical Cannabis Sales License
Efixii App Gains Health Canada Cannabis-Consultation Feature for $600 Million MarketVANCOUVER, British Columbia, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Global...
ACTIVE BIOTECH ENTERS INTO A MANUFACTURING AGREEMENT WITH FAMAR HEALTH CARE SERVICES FOR NEW FORMULATION OF LAQUINIMOD
Active Biotech AB (publ) (NASDAQ STOCKHOLM: ACTI) today announced it has reached a manufacturing agreement with Famar Health Care Services...
Biogen Announces Private Exchange Offer for 5.200% Senior Notes Due 2045 Open to Certain Investors
CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (“Biogen”) (Nasdaq: BIIB) today announced the commencement of a private...
Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2020 Financial Results and Corporate Update
NOVATO, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development...
Agenus Announces Positive Preliminary Results of iNKT Cell Therapy Trial in COVID-19
3 out of 4 intubated patients were discharged after treatment2 out of 4 patients were extubated within 24 hours of...
InspireMD Announces Pricing of Upsized $18 Million Underwritten Public Offering
TEL AVIV, Israel, Feb. 04, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. ("InspireMD") (NYSE:NSPR), a medical device company focused on the...
Turning Point Therapeutics to Participate in Guggenheim Healthcare Talks 2021 Oncology Days
Company to Participate in Two Q&A Sessions, Including a Joint Discussion with Zai LabSAN DIEGO, Feb. 04, 2021 (GLOBE NEWSWIRE)...
New Research Demonstrates the Clinical Utility with Daxor’s Blood Volume Analyzer (BVA-100®) in Critical Care
Study Presented At the Society for Critical Care Medicine (SCCM) 50th Congress NEW YORK, Feb. 04, 2021 (GLOBE NEWSWIRE) --...
Nemaura Medical Appoints Thomas Mortensen as Head of E.U. Commercial Operations and Marketing
Loughborough, England, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology...
Replimune Reports Third Fiscal Quarter Financial Results and Provides Corporate Update
RP1: Initial data in new indications expected in 2021 in anti-PD1 failed NSCLC, anti-PD1 failed CSCC and CSCC solid organ...
Gain Therapeutics Announces Three Late-Breaker Presentations at the 17th Annual WORLDSymposium
BETHESDA, Md., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc., (“Gain”) a biotechnology company focused on redefining drug discovery...
ICU Medical, Inc. Announces Time of Fourth Quarter and Fiscal Year 2020 Earnings Conference Call
SAN CLEMENTE, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and...